| Sep 18 |
Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer
|
| Sep 9 |
Exploring High Growth Tech Stocks in the United States for September 2024
|
| Sep 5 |
Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period
|
| Sep 1 |
Wall Street Breakfast: The Week Ahead
|
| Aug 18 |
Wall Street Breakfast: The Week Ahead
|
| Aug 11 |
Wall Street Breakfast: The Week Ahead
|
| Aug 8 |
Pharmacosmos ventures into oncology and merges with G1 Therapeutics
|
| Aug 8 |
G1 Therapeutics (GTHX) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 8 |
G1 Therapeutics GAAP EPS of -$0.10 beats by $0.07, revenue of $16.55M beats by $0.52M
|
| Aug 8 |
G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights
|
